Now, it looks like the upcoming Asus ROG VR gaming headset will be the first to deliver on that promise. According to notable leaker Luna on X, the Asus ROG VR headset to likely to be the first ...
4G bands 1, 2, 3, 4, 5, 7, 8, 12, 17, 18, 19, 20, 25, 26, 28, 32, 34, 38, 39, 40, 41, 42, 43, 48, 66 - International 1, 2, 3, 4, 5, 7, 8, 12, 17, 18, 19, 20, 25, 26 ...
Admittedly, you can fill a 512GB SSD fairly quickly these days, but the ROG Ally has a microSD card slot that allows you to expand your storage for cheap. For instance, you can grab a SanDisk ...
Best ASUS ROG Ally and Ally X accessories in 2025: MicroSD cards, carrying cases, adapters, and more
If you anticipate needing a ton of extra space for gaming on the ROG Ally then you need a high-capacity SD Card to do the trick. SanDisk is the brand that I trust most and this 1TB card will give ...
From heartfelt callbacks to pop culture touchstones, this year’s Big Game advertisers are proving that sometimes, looking back is the best way forward. Hellmann’s is scoring big with nostalgia ...
Created by the luxury brand’s in-house team, the spot puts connection at the forefront to celebrate the Year of the Snake. Ni Ni and Xiao Zhan star in Gucci’s Lunar New Year film that puts ...
Of all the big debates in the handheld gaming space, few are as competitive as the Asus ROG Ally X vs Steam Deck OLED battle. This pair of portable PCs are two of the most powerful and popular on the ...
5G bands 1, 2, 3, 5, 7, 8, 12, 18, 20, 25, 26, 28, 38, 40, 41, 48, 66, 77, 78, 79 SA/NSA/Sub6 - International 1, 2, 3, 5, 7, 8, 12, 18, 20, 25, 26, 29, 38, 40, 41, 48 ...
Alongside their ROG Scar lineups, Asus are also updating their more mainstream ROG Strix G models for 2025. These Strix Gs G615/G815 are a brand-new designs for the year and share many characteristics ...
Asus stick to their two-year update schedule of their major ROG lineups, and that means early 2025 brings brand-new iterations of their full-size ROG Strix Scar and ROG Strix models. In this article, ...
Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema treatment, Dupixent, and announced a dividend and stock buyback program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results